BioStem Technologies (OTCMKTS:BSEM) Trading Down 0.2% - Time to Sell?

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report)'s stock price traded down 0.2% during mid-day trading on Monday . The company traded as low as $10.91 and last traded at $11.98. 41,955 shares changed hands during mid-day trading, a decline of 38% from the average session volume of 67,777 shares. The stock had previously closed at $12.00.

BioStem Technologies Price Performance

The stock has a market capitalization of $184.85 million, a price-to-earnings ratio of 16.27 and a beta of -0.10. The business has a 50 day simple moving average of $11.57 and a 200-day simple moving average of $13.29.

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($1.08). The business had revenue of $72.53 million during the quarter, compared to analysts' expectations of $101.20 million. As a group, equities analysts predict that BioStem Technologies, Inc. will post 1.41 earnings per share for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.